ArticleInvestigational new drugs2018

PIK3CA mutation sensitizes breast cancer cells to synergistic therapy of PI3K inhibition and AMPK activation.

Songlin Liu et al.PubMed ↗Publisher ↗

No numbers read from the abstract.